Fludarabine/Clofarabine/Busulfan combined with SAHA in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation for Acute Leukemia
Status: Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 26 Sep 2018
Price : $35 *
At a glance
- Drugs Vorinostat (Primary) ; Busulfan; Clofarabine; Fludarabine
- Indications Acute myeloid leukaemia; Leukaemia; Myelodysplastic syndromes; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions
- Acronyms SAHA
- 10 May 2018 Status changed from recruiting to active, no longer recruiting.
- 21 Mar 2018 Planned End Date changed from 1 Mar 2019 to 1 Mar 2021.
- 21 Mar 2018 Planned primary completion date changed from 1 Mar 2019 to 1 Mar 2020.